144 related articles for article (PubMed ID: 30189188)
1. Haptoglobin phenotype is a critical factor in the use of fucosylated haptoglobin for pancreatic cancer diagnosis.
Morishita K; Ito N; Koda S; Maeda M; Nakayama K; Yoshida K; Takamatsu S; Yamada M; Eguchi H; Kamada Y; Miyoshi E
Clin Chim Acta; 2018 Dec; 487():84-89. PubMed ID: 30189188
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.
Shimomura M; Nakayama K; Azuma K; Terao N; Nishino K; Takamatsu S; Nakano M; Takahashi S; Kobayashi Y; Murata K; Kamada Y; Miyoshi E
Clin Chim Acta; 2015 Jun; 446():30-6. PubMed ID: 25861849
[TBL] [Abstract][Full Text] [Related]
3. Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.
Kamada Y; Kinoshita N; Tsuchiya Y; Kobayashi K; Fujii H; Terao N; Kamihagi K; Koyama N; Yamada S; Daigo Y; Nakamura Y; Taniguchi N; Miyoshi E
Clin Chim Acta; 2013 Feb; 417():48-53. PubMed ID: 23262369
[TBL] [Abstract][Full Text] [Related]
4. Specific increase in serum core-fucosylated haptoglobin in patients with chronic pancreatitis.
Ueda M; Kamada Y; Takamatsu S; Shimomura M; Maekawa T; Sobajima T; Fujii H; Nakayama K; Nishino K; Yamada M; Kobayashi Y; Kumada T; Ito T; Eguchi H; Nagano H; Miyoshi E
Pancreatology; 2016; 16(2):238-43. PubMed ID: 26897254
[TBL] [Abstract][Full Text] [Related]
5. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer.
Takeda Y; Shinzaki S; Okudo K; Moriwaki K; Murata K; Miyoshi E
Cancer; 2012 Jun; 118(12):3036-43. PubMed ID: 22006099
[TBL] [Abstract][Full Text] [Related]
6. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
[TBL] [Abstract][Full Text] [Related]
7. Serum fucosylated haptoglobin as a novel prognostic biomarker predicting high-Gleason prostate cancer.
Fujita K; Shimomura M; Uemura M; Nakata W; Sato M; Nagahara A; Nakai Y; Takamatsu S; Miyoshi E; Nonomura N
Prostate; 2014 Jul; 74(10):1052-8. PubMed ID: 24802742
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an antibody specific for cancer-associated haptoglobin: a possible implication of clinical investigation.
Nishino K; Koda S; Kataoka N; Takamatsu S; Nakano M; Ikeda S; Kamamatsu Y; Morishita K; Moriwaki K; Eguchi H; Yamamoto E; Kikkawa F; Tomita Y; Kamada Y; Miyoshi E
Oncotarget; 2018 Feb; 9(16):12732-12744. PubMed ID: 29560105
[TBL] [Abstract][Full Text] [Related]
9. Identification of the epitope of 10-7G glycan antibody to recognize cancer-associated haptoglobin.
Morishita K; Maki Y; Takamatsu S; Ito N; Koda S; Motooka K; Kamada Y; Kajihara Y; Miyoshi E
Anal Biochem; 2020 Mar; 593():113588. PubMed ID: 31981485
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
Tawara S; Tatsumi T; Iio S; Kobayashi I; Shigekawa M; Hikita H; Sakamori R; Hiramatsu N; Miyoshi E; Takehara T
PLoS One; 2016; 11(3):e0151828. PubMed ID: 27002630
[TBL] [Abstract][Full Text] [Related]
11. Reevaluation of Pholiota squarrosa lectin-reactive haptoglobin as a pancreatic cancer biomarker using an improved ELISA system.
Kusama K; Okamoto Y; Saito K; Kasahara T; Murata T; Ueno Y; Kobayashi Y; Kamada Y; Miyoshi E
Glycoconj J; 2017 Aug; 34(4):537-544. PubMed ID: 28455724
[TBL] [Abstract][Full Text] [Related]
12. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.
Kamada Y; Akita M; Takeda Y; Yamada S; Fujii H; Sawai Y; Doi Y; Asazawa H; Nakayama K; Mizutani K; Fujii H; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E
PLoS One; 2013; 8(6):e66328. PubMed ID: 23805214
[TBL] [Abstract][Full Text] [Related]
13. Detection of fucosylated haptoglobin using the 10-7G antibody as a biomarker for evaluating endoscopic remission in ulcerative colitis.
Motooka K; Morishita K; Ito N; Shinzaki S; Tashiro T; Nojima S; Shimizu K; Date M; Sakata N; Yamada M; Takamatsu S; Kamada Y; Iijima H; Mizushima T; Morii E; Takehara T; Miyoshi E
World J Gastroenterol; 2021 Jan; 27(2):162-175. PubMed ID: 33510557
[TBL] [Abstract][Full Text] [Related]
14. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
Shang S; Qin X; Li W; Zhang S; Liu Y
Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
[TBL] [Abstract][Full Text] [Related]
15. Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.
Miyoshi E; Shinzaki S; Moriwaki K; Matsumoto H
Methods Enzymol; 2010; 478():153-64. PubMed ID: 20816478
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.
Matsumoto H; Shinzaki S; Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Kanke F; Satomura S; Kumada T; Miyoshi E
Clin Chem Lab Med; 2010 Apr; 48(4):505-12. PubMed ID: 20128732
[TBL] [Abstract][Full Text] [Related]
17. Application of glycoscience to the early detection of pancreatic cancer.
Miyoshi E; Kamada Y
Cancer Sci; 2016 Oct; 107(10):1357-1362. PubMed ID: 27418030
[TBL] [Abstract][Full Text] [Related]
18. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: possible implication for the differential diagnosis of cancer.
Takahashi S; Sugiyama T; Shimomura M; Kamada Y; Fujita K; Nonomura N; Miyoshi E; Nakano M
Glycoconj J; 2016 Jun; 33(3):471-82. PubMed ID: 26869352
[TBL] [Abstract][Full Text] [Related]
19. Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures.
Miyoshi E; Nakano M
Proteomics; 2008 Aug; 8(16):3257-62. PubMed ID: 18646007
[TBL] [Abstract][Full Text] [Related]
20. Identification of an inducible factor secreted by pancreatic cancer cell lines that stimulates the production of fucosylated haptoglobin in hepatoma cells.
Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Nakagawa T; Matsumoto H; Asahi M; Koyama N; Miyoshi E
Biochem Biophys Res Commun; 2008 Dec; 377(3):792-6. PubMed ID: 18951869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
